CHARLES CHUANHAI GUO

Concepts (366)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
55
2024
2442
8.010
Why?
Carcinoma, Transitional Cell
29
2024
1007
4.940
Why?
Neoplasms, Germ Cell and Embryonal
11
2024
346
3.670
Why?
Testicular Neoplasms
14
2024
560
3.640
Why?
Urothelium
17
2024
264
2.780
Why?
Ureteral Neoplasms
16
2024
238
2.380
Why?
Biomarkers, Tumor
28
2024
10731
1.720
Why?
Teratoma
5
2023
248
1.620
Why?
Kidney Neoplasms
22
2024
3116
1.570
Why?
Sarcoma
5
2023
1851
1.540
Why?
Adenocarcinoma
15
2023
7920
1.510
Why?
Urinary Bladder
7
2021
592
1.460
Why?
Oncogene Proteins, Fusion
5
2017
796
1.370
Why?
Ureter
11
2023
218
1.310
Why?
Carcinoma, Small Cell
5
2018
426
1.280
Why?
Neoplasm Invasiveness
18
2024
4054
1.270
Why?
Nephroureterectomy
4
2024
48
1.200
Why?
BCG Vaccine
9
2024
430
1.180
Why?
Immunohistochemistry
21
2024
7647
1.140
Why?
Cystectomy
17
2024
637
1.130
Why?
Carcinoma
11
2022
2609
1.080
Why?
Epithelioid Cells
2
2024
45
1.030
Why?
Prostatic Neoplasms
16
2022
5870
1.010
Why?
Trophoblastic Neoplasms
1
2024
23
0.960
Why?
Mucous Membrane
4
2024
258
0.950
Why?
Urologic Neoplasms
7
2024
204
0.930
Why?
Disease Progression
11
2024
6881
0.880
Why?
Carcinoma, Neuroendocrine
6
2023
742
0.860
Why?
Hematuria
2
2019
83
0.800
Why?
Neuroectodermal Tumors, Primitive, Peripheral
1
2022
36
0.780
Why?
Male
84
2024
128520
0.750
Why?
Neoplasm Recurrence, Local
26
2023
10409
0.740
Why?
Carcinoma, Signet Ring Cell
1
2022
180
0.740
Why?
GATA3 Transcription Factor
3
2020
144
0.730
Why?
Middle Aged
64
2024
90569
0.720
Why?
Gene Fusion
3
2011
214
0.710
Why?
Aged
60
2024
73640
0.710
Why?
Humans
118
2024
270804
0.700
Why?
Perivascular Epithelioid Cell Neoplasms
1
2019
12
0.690
Why?
Muscle, Smooth
2
2020
250
0.690
Why?
Epithelial-Mesenchymal Transition
3
2024
1002
0.680
Why?
Carcinogenesis
3
2024
1033
0.660
Why?
Wilms Tumor
1
2022
302
0.650
Why?
Urogenital System
1
2019
60
0.650
Why?
Uroplakin II
2
2016
15
0.630
Why?
Aged, 80 and over
32
2024
31117
0.600
Why?
Adult
44
2024
82073
0.590
Why?
Carcinoma, Papillary
4
2021
566
0.590
Why?
Seminoma
6
2014
86
0.580
Why?
Carcinoma, Squamous Cell
7
2020
5606
0.570
Why?
Neoplasms, Complex and Mixed
1
2017
42
0.570
Why?
DNA Copy Number Variations
1
2024
1576
0.560
Why?
Neuroectodermal Tumors, Primitive
1
2017
98
0.540
Why?
Adjuvants, Immunologic
7
2024
669
0.530
Why?
Kidney Pelvis
3
2017
113
0.530
Why?
Neoplasm Grading
10
2024
1828
0.500
Why?
Uroplakin III
1
2014
8
0.490
Why?
Retrospective Studies
34
2024
39982
0.490
Why?
Biopsy
8
2024
3490
0.460
Why?
Urinary Tract
3
2023
87
0.450
Why?
Neoplasms, Multiple Primary
3
2021
557
0.450
Why?
Adenocarcinoma, Follicular
2
2014
131
0.440
Why?
Female
51
2024
148936
0.440
Why?
Prognosis
26
2024
22533
0.420
Why?
Sarcoma, Ewing
1
2017
428
0.420
Why?
Carcinosarcoma
1
2014
145
0.420
Why?
Nephrectomy
11
2014
793
0.400
Why?
Orchiectomy
4
2022
211
0.390
Why?
Angiomyolipoma
2
2010
30
0.390
Why?
Chondrosarcoma
1
2014
213
0.390
Why?
Mutation
6
2024
15922
0.370
Why?
Prostatectomy
7
2022
1004
0.360
Why?
Fatal Outcome
4
2017
818
0.360
Why?
Urogenital Neoplasms
2
2024
118
0.340
Why?
Young Adult
15
2024
22255
0.340
Why?
Hemangiosarcoma
2
2010
238
0.330
Why?
Administration, Intravesical
4
2023
171
0.330
Why?
RNA, Messenger
3
2016
6344
0.330
Why?
Carcinoma in Situ
3
2016
489
0.330
Why?
DNA Mutational Analysis
3
2024
2356
0.310
Why?
Carcinoma, Renal Cell
3
2024
2394
0.300
Why?
In Situ Hybridization, Fluorescence
4
2024
2312
0.300
Why?
Cisplatin
7
2023
2509
0.280
Why?
Transcriptome
1
2016
1960
0.280
Why?
Carcinoma, Large Cell
2
2021
98
0.280
Why?
Tissue Array Analysis
4
2016
757
0.270
Why?
Survival Rate
16
2017
12535
0.270
Why?
Bone Neoplasms
2
2017
2674
0.270
Why?
Carcinoma, Verrucous
1
2006
14
0.270
Why?
Neoplasm Staging
18
2024
14037
0.270
Why?
Chorionic Gonadotropin, beta Subunit, Human
2
2024
56
0.260
Why?
Endodermal Sinus Tumor
4
2013
50
0.260
Why?
Treatment Outcome
19
2024
33859
0.250
Why?
Gene Expression Regulation, Neoplastic
9
2024
9047
0.250
Why?
Carcinoma, Ductal
1
2006
144
0.250
Why?
Combined Modality Therapy
10
2023
9054
0.240
Why?
Gene Expression Profiling
8
2020
5146
0.230
Why?
ADP-ribosyl Cyclase 1
1
2024
149
0.230
Why?
Cytodiagnosis
1
2024
201
0.220
Why?
Neoplasms, Second Primary
2
2022
1388
0.220
Why?
Diagnosis, Differential
5
2020
4839
0.220
Why?
TOR Serine-Threonine Kinases
2
2024
1536
0.210
Why?
World Health Organization
1
2024
321
0.210
Why?
Organ Sparing Treatments
1
2024
283
0.200
Why?
Tertiary Care Centers
1
2024
419
0.200
Why?
Gene Rearrangement
2
2019
809
0.200
Why?
Folic Acid Antagonists
1
2022
48
0.200
Why?
Lymphatic Metastasis
11
2014
4969
0.200
Why?
Mycobacterium bovis
1
2022
68
0.200
Why?
Synaptophysin
2
2011
83
0.190
Why?
Transgender Persons
1
2022
62
0.190
Why?
Genomics
3
2022
2834
0.190
Why?
Tumor Suppressor Protein p53
3
2024
3656
0.190
Why?
Sensitivity and Specificity
4
2020
5157
0.180
Why?
Telomerase
1
2024
544
0.180
Why?
Neoplasm Metastasis
7
2017
5332
0.180
Why?
Keratin-6
1
2020
40
0.180
Why?
Keratin-5
1
2020
57
0.180
Why?
Kaplan-Meier Estimate
7
2018
6259
0.180
Why?
Patient Selection
3
2024
2032
0.180
Why?
Rectal Neoplasms
1
2009
1240
0.180
Why?
Chromosomes, Human, Pair 9
1
2021
298
0.180
Why?
Pathology
1
2021
102
0.170
Why?
Antibodies, Monoclonal
2
2024
4470
0.170
Why?
Leiomyosarcoma
3
2010
253
0.170
Why?
Down-Regulation
2
2016
2087
0.170
Why?
Databases, Genetic
2
2020
758
0.170
Why?
Adolescent
8
2022
32698
0.160
Why?
MicroRNAs
3
2019
2883
0.160
Why?
Cell Differentiation
2
2024
4102
0.160
Why?
Urology
1
2020
140
0.160
Why?
Immunotherapy
4
2021
3561
0.160
Why?
Carcinoma, Embryonal
3
2013
31
0.160
Why?
Androgen Antagonists
2
2022
420
0.160
Why?
Pathologists
1
2019
101
0.150
Why?
Retinoblastoma Binding Proteins
1
2018
66
0.150
Why?
Lymph Node Excision
6
2014
2068
0.150
Why?
Mutagenesis
1
2019
509
0.150
Why?
Texas
4
2018
6445
0.150
Why?
Follow-Up Studies
8
2017
15280
0.140
Why?
Whole Genome Sequencing
2
2017
367
0.140
Why?
Neoadjuvant Therapy
5
2022
5247
0.140
Why?
Clonal Evolution
1
2019
250
0.140
Why?
Chromosome Deletion
1
2021
1057
0.140
Why?
Disease-Free Survival
11
2021
10268
0.140
Why?
Neoplasms, Basal Cell
1
2016
32
0.140
Why?
RNA-Binding Proteins
2
2013
1016
0.140
Why?
Muscle Neoplasms
1
2017
108
0.140
Why?
Keratin-14
1
2016
24
0.130
Why?
Chemotherapy, Adjuvant
7
2021
4007
0.130
Why?
Nanomedicine
1
2016
53
0.130
Why?
ATPases Associated with Diverse Cellular Activities
1
2016
86
0.130
Why?
Lung Neoplasms
4
2014
12045
0.130
Why?
Cell Transdifferentiation
1
2017
114
0.130
Why?
Multigene Family
1
2017
469
0.130
Why?
Aurora Kinase A
1
2017
209
0.130
Why?
Proto-Oncogene Proteins p21(ras)
1
2022
1404
0.130
Why?
Neoplasms, Hormone-Dependent
1
2017
347
0.120
Why?
Survival Analysis
4
2020
9281
0.120
Why?
Gene Silencing
1
2018
825
0.120
Why?
Prostate-Specific Antigen
4
2012
1030
0.120
Why?
Hyaluronan Receptors
1
2016
247
0.120
Why?
PPAR gamma
1
2016
224
0.120
Why?
Gene Regulatory Networks
1
2019
679
0.120
Why?
Plasmids
1
2016
923
0.110
Why?
Urethral Neoplasms
1
2014
62
0.110
Why?
Liposomes
1
2016
708
0.110
Why?
Receptor, ErbB-2
1
2024
2659
0.110
Why?
Virus Integration
1
2014
73
0.110
Why?
Liver Neoplasms
1
2011
4843
0.110
Why?
HSP72 Heat-Shock Proteins
1
2013
14
0.110
Why?
Transcription, Genetic
2
2019
3328
0.110
Why?
Tumor Microenvironment
2
2021
3054
0.110
Why?
Proportional Hazards Models
3
2021
5099
0.110
Why?
DNA Helicases
1
2016
459
0.110
Why?
Predictive Value of Tests
2
2021
4966
0.110
Why?
Retroperitoneal Space
1
2013
156
0.110
Why?
Ubiquitin-Protein Ligases
1
2018
866
0.110
Why?
Societies, Medical
1
2019
1323
0.100
Why?
Hyperplasia
2
2022
571
0.100
Why?
Antineoplastic Agents, Immunological
2
2020
1338
0.100
Why?
Genetic Predisposition to Disease
2
2024
5779
0.100
Why?
Neoplastic Cells, Circulating
1
2017
637
0.100
Why?
PTEN Phosphohydrolase
1
2017
1011
0.100
Why?
Practice Patterns, Physicians'
1
2020
1301
0.100
Why?
Antineoplastic Agents, Hormonal
1
2017
841
0.100
Why?
Prostatic Intraepithelial Neoplasia
2
2014
81
0.100
Why?
Chromogranins
1
2011
87
0.100
Why?
Acid Phosphatase
1
2011
56
0.100
Why?
Boronic Acids
1
2013
355
0.100
Why?
Oncogene Fusion
1
2011
62
0.100
Why?
Translocation, Genetic
1
2017
1286
0.090
Why?
Phenotype
2
2020
6503
0.090
Why?
Chromogranin A
1
2011
67
0.090
Why?
Kidney
3
2021
2102
0.090
Why?
Cell Death
1
2013
685
0.090
Why?
DNA Methylation
2
2019
2769
0.090
Why?
Receptors, Platelet-Derived Growth Factor
1
2011
109
0.090
Why?
Keratins
1
2011
340
0.090
Why?
Case-Control Studies
1
2020
6234
0.090
Why?
Protein Tyrosine Phosphatases
1
2011
189
0.090
Why?
Viscera
1
2010
88
0.090
Why?
Neuroendocrine Tumors
1
2017
656
0.090
Why?
Pyrazines
1
2013
511
0.090
Why?
Lymph Nodes
2
2013
3081
0.090
Why?
Clinical Trials as Topic
2
2018
3841
0.090
Why?
Multimodal Imaging
1
2014
551
0.090
Why?
Biopsy, Needle
2
2021
1381
0.090
Why?
Protein Kinases
1
2014
889
0.080
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2014
690
0.080
Why?
Serine Endopeptidases
1
2010
271
0.080
Why?
ErbB Receptors
2
2009
2376
0.080
Why?
Transcription Factors
2
2016
5415
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2020
3429
0.080
Why?
Leiomyoma
1
2010
162
0.080
Why?
Transplantation, Heterologous
1
2010
1054
0.080
Why?
Chromatin
1
2014
1041
0.080
Why?
Positron-Emission Tomography
2
2014
2199
0.080
Why?
Time Factors
3
2017
12979
0.080
Why?
Radiopharmaceuticals
1
2014
1342
0.080
Why?
Cell Nucleus
3
2010
1715
0.080
Why?
Image-Guided Biopsy
2
2021
336
0.080
Why?
Fluorodeoxyglucose F18
1
2014
1260
0.080
Why?
Cell Cycle
1
2014
2135
0.070
Why?
Tumor Suppressor Proteins
1
2016
1902
0.070
Why?
Carcinoid Tumor
1
2010
282
0.070
Why?
Biopsy, Fine-Needle
1
2011
690
0.070
Why?
Carrier Proteins
1
2016
2084
0.070
Why?
Neoplasm Transplantation
1
2010
1553
0.070
Why?
Drug Resistance, Neoplasm
1
2021
5417
0.070
Why?
Oxidative Stress
1
2014
1152
0.070
Why?
Phosphatidylinositol 3-Kinases
1
2014
1704
0.070
Why?
Molecular Targeted Therapy
2
2016
2396
0.070
Why?
Proto-Oncogene Proteins c-akt
1
2014
2050
0.070
Why?
Condylomata Acuminata
1
2006
32
0.070
Why?
Health Surveys
2
2020
395
0.070
Why?
Child
4
2017
30572
0.070
Why?
Mediastinal Neoplasms
1
2010
428
0.060
Why?
Quinazolines
1
2011
956
0.060
Why?
Animals
5
2024
61362
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
16751
0.060
Why?
Prostate
1
2010
1090
0.060
Why?
Nuclear Proteins
2
2019
3435
0.060
Why?
In Situ Hybridization
1
2006
1043
0.060
Why?
Ureteroscopy
1
2024
51
0.060
Why?
Trans-Activators
1
2010
1626
0.060
Why?
Cluster Analysis
2
2017
1076
0.060
Why?
Tomography, X-Ray Computed
3
2016
7789
0.060
Why?
Receptors, Lysophosphatidic Acid
1
2024
89
0.060
Why?
Necrosis
3
2010
591
0.060
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2024
67
0.060
Why?
Disease Models, Animal
1
2017
7323
0.060
Why?
Signal Transduction
3
2021
12036
0.060
Why?
Salvage Therapy
1
2012
2124
0.060
Why?
Mitosis
3
2010
681
0.050
Why?
Melanoma
1
2020
5601
0.050
Why?
Laparoscopy
2
2009
1304
0.050
Why?
Papillomaviridae
1
2006
636
0.050
Why?
Risk Factors
5
2021
17867
0.050
Why?
Pilot Projects
2
2024
2855
0.050
Why?
Gender Identity
1
2022
80
0.050
Why?
Survivorship
1
2022
116
0.050
Why?
Piperazines
1
2011
2143
0.050
Why?
Atrophy
1
2022
271
0.050
Why?
Terminology as Topic
1
2024
414
0.050
Why?
Xenograft Model Antitumor Assays
1
2010
3930
0.050
Why?
Hormones
1
2022
284
0.050
Why?
Proto-Oncogene Proteins
1
2010
2618
0.050
Why?
Phenylurea Compounds
1
2024
600
0.040
Why?
alpha-Fetoproteins
2
2013
256
0.040
Why?
Risk Assessment
3
2021
6766
0.040
Why?
Membrane Glycoproteins
1
2024
1091
0.040
Why?
Child, Preschool
2
2013
17083
0.040
Why?
Immune Tolerance
1
2021
434
0.040
Why?
Homozygote
1
2021
771
0.040
Why?
Glomerular Filtration Rate
1
2022
589
0.040
Why?
Molecular Diagnostic Techniques
1
2021
333
0.040
Why?
Mice
3
2024
35420
0.040
Why?
Deoxycytidine
1
2023
1389
0.040
Why?
Sequence Analysis, Protein
1
2017
80
0.040
Why?
Snail Family Transcription Factors
1
2017
119
0.040
Why?
United States Food and Drug Administration
1
2018
326
0.040
Why?
Prospective Studies
2
2022
13422
0.030
Why?
Receptors, Transferrin
1
2016
41
0.030
Why?
Mutation Rate
1
2017
220
0.030
Why?
Vinblastine
1
2017
462
0.030
Why?
Cell Line, Tumor
3
2017
14885
0.030
Why?
CTLA-4 Antigen
1
2020
679
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
1033
0.030
Why?
Consensus
1
2021
1113
0.030
Why?
Single-Chain Antibodies
1
2016
61
0.030
Why?
United States
4
2018
15834
0.030
Why?
Retinoblastoma Protein
1
2016
339
0.030
Why?
B7-H1 Antigen
1
2021
1098
0.030
Why?
Databases, Factual
1
2021
2261
0.030
Why?
Transgenes
1
2016
568
0.030
Why?
Magnetic Resonance Imaging
2
2021
7923
0.030
Why?
Programmed Cell Death 1 Receptor
1
2020
1096
0.030
Why?
Methotrexate
1
2017
1025
0.030
Why?
Sequence Analysis, RNA
1
2017
674
0.030
Why?
Multivariate Analysis
2
2012
4320
0.030
Why?
False Positive Reactions
1
2014
374
0.030
Why?
Radiography, Abdominal
1
2014
128
0.030
Why?
Bone Morphogenetic Protein 2
1
2013
123
0.030
Why?
Magnetic Resonance Angiography
1
2014
219
0.030
Why?
Gene Transfer Techniques
1
2016
800
0.030
Why?
Mice, Inbred C57BL
1
2024
7054
0.030
Why?
Antineoplastic Agents
5
2016
14639
0.030
Why?
Observer Variation
1
2014
709
0.030
Why?
Microarray Analysis
1
2013
396
0.030
Why?
Glutathione Transferase
1
2013
364
0.030
Why?
Chromatin Immunoprecipitation
1
2013
506
0.020
Why?
Reproducibility of Results
2
2014
6193
0.020
Why?
Transforming Growth Factor beta
1
2017
1105
0.020
Why?
Immunoblotting
1
2013
887
0.020
Why?
Bortezomib
1
2013
551
0.020
Why?
Pyrimidines
1
2024
3671
0.020
Why?
Preoperative Care
1
2017
1582
0.020
Why?
Protein Isoforms
1
2013
843
0.020
Why?
Statistics as Topic
1
2012
448
0.020
Why?
DNA Primers
1
2013
1489
0.020
Why?
Computational Biology
1
2017
1295
0.020
Why?
Pancreatic Neoplasms
1
2008
5264
0.020
Why?
Genome, Human
1
2019
1896
0.020
Why?
Choriocarcinoma
1
2010
49
0.020
Why?
Sialoglycoproteins
1
2010
149
0.020
Why?
Gene Knockdown Techniques
1
2013
1072
0.020
Why?
Peritoneum
1
2011
151
0.020
Why?
Octamer Transcription Factor-3
1
2010
105
0.020
Why?
Doxorubicin
1
2017
3147
0.020
Why?
Chile
1
2009
69
0.020
Why?
Giant Cells
1
2010
73
0.020
Why?
Antigens, Surface
1
2010
304
0.020
Why?
Proteoglycans
1
2010
278
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2013
1195
0.020
Why?
Japan
1
2009
240
0.020
Why?
Ki-1 Antigen
1
2010
186
0.020
Why?
Cell Count
1
2010
509
0.020
Why?
Cell Movement
1
2017
2468
0.020
Why?
North America
1
2009
337
0.020
Why?
Spermatozoa
1
2011
292
0.020
Why?
Urologic Surgical Procedures
1
2009
93
0.020
Why?
Research Design
1
2016
1562
0.020
Why?
Early Detection of Cancer
1
2017
1345
0.020
Why?
Genetic Therapy
1
2016
1715
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2010
485
0.020
Why?
Epidemiologic Methods
1
2008
249
0.020
Why?
Europe
1
2009
650
0.020
Why?
Neoplasm, Residual
1
2014
1761
0.020
Why?
Contrast Media
1
2014
1505
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
3582
0.020
Why?
Drug Therapy
1
2007
205
0.020
Why?
Mice, SCID
1
2010
1825
0.020
Why?
Rhabdomyosarcoma
1
2010
342
0.020
Why?
Physicians
1
2014
854
0.020
Why?
Drug Administration Schedule
1
2011
3533
0.020
Why?
Chemoradiotherapy
1
2014
2038
0.020
Why?
Sex Factors
1
2010
2180
0.010
Why?
Cell Proliferation
1
2017
7233
0.010
Why?
Cohort Studies
1
2016
9464
0.010
Why?
Cell Transformation, Neoplastic
1
2012
2454
0.010
Why?
Thyroid Neoplasms
1
2014
1908
0.010
Why?
Proteins
1
2010
2030
0.010
Why?
Radiotherapy
1
2007
1858
0.010
Why?
Neoplasms
1
2021
15951
0.010
Why?
Infant
1
2009
14003
0.010
Why?
GUO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (366)
Explore
_
Co-Authors (83)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_